Novavax, Inc. Share Price
NASDAQ: NVAX | Small CapNovavax, Inc. Stock Performance
Novavax, Inc. Share Price Today
As of 9 October 2026, Novavax, Inc.'s share price is $11.00. The stock opened at $10.95, compared to its previous close of $11.24. During today's trading session, Novavax, Inc.'s share price traded between $10.77 and $11.13, with an average price of $10.95. Over the past 52 weeks, the stock has recorded a high of $13.38 and a low of $6.21. In terms of performance, Novavax, Inc.'s share price has risen by 38.89% over the last six months and is up 30.80% on a year-on-year basis.
Novavax, Inc. Share Price Chart
Novavax, Inc. Quarterly Profit & Loss
All figures in USD
Novavax, Inc. Annual Profit & Loss
All figures in USD
About Novavax, Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Novavax, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $10.79 | $11.01 | +1.48% |
Sep 2026 | $9.20 | $10.85 | +19.70% |
Aug 2026 | $7.35 | $9.06 | +23.94% |
Jul 2026 | $9.37 | $7.31 | -22.40% |
Jun 2026 | $10.82 | $9.42 | -14.05% |
May 2026 | $7.88 | $10.96 | +38.38% |
Apr 2026 | $8.22 | $7.92 | -2.82% |
Mar 2026 | $9.76 | $8.15 | -19.63% |
Feb 2026 | $8.65 | $10.14 | +14.58% |
Jan 2026 | $6.79 | $8.85 | +31.50% |
Dec 2025 | $6.83 | $6.73 | -4.54% |
Nov 2025 | $8.31 | $7.05 | -16.17% |